Standard
Serum osteoprotegerin as a long-term predictor for patients with stable coronary artery disease and its association with diabetes and statin treatment: A CLARICOR trial 10-year follow-up substudy. / Bjerre, Mette; Hilden, Jorgen; Winkel, Per; Jensen, Gorm Boje; Kjøller, Erik; Sajadieh, Ahmad; Kastrup, Jens; Kolmos, Hans Jorn; Larsson, Anders; Arnlov, Johan; Jakobsen, Janus Christian; Gluud, Christian.
In:
Atherosclerosis, Vol. 301, 2020, p. 8-14.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Bjerre, M
, Hilden, J, Winkel, P, Jensen, GB, Kjøller, E
, Sajadieh, A, Kastrup, J, Kolmos, HJ, Larsson, A, Arnlov, J, Jakobsen, JC & Gluud, C 2020, '
Serum osteoprotegerin as a long-term predictor for patients with stable coronary artery disease and its association with diabetes and statin treatment: A CLARICOR trial 10-year follow-up substudy',
Atherosclerosis, vol. 301, pp. 8-14.
https://doi.org/10.1016/j.atherosclerosis.2020.03.030APA
Bjerre, M.
, Hilden, J., Winkel, P., Jensen, G. B., Kjøller, E.
, Sajadieh, A., Kastrup, J., Kolmos, H. J., Larsson, A., Arnlov, J., Jakobsen, J. C., & Gluud, C. (2020).
Serum osteoprotegerin as a long-term predictor for patients with stable coronary artery disease and its association with diabetes and statin treatment: A CLARICOR trial 10-year follow-up substudy.
Atherosclerosis,
301, 8-14.
https://doi.org/10.1016/j.atherosclerosis.2020.03.030Vancouver
Bjerre M
, Hilden J, Winkel P, Jensen GB, Kjøller E
, Sajadieh A et al.
Serum osteoprotegerin as a long-term predictor for patients with stable coronary artery disease and its association with diabetes and statin treatment: A CLARICOR trial 10-year follow-up substudy.
Atherosclerosis. 2020;301:8-14.
https://doi.org/10.1016/j.atherosclerosis.2020.03.030Author
Bjerre, Mette ; Hilden, Jorgen ; Winkel, Per ; Jensen, Gorm Boje ; Kjøller, Erik ; Sajadieh, Ahmad ; Kastrup, Jens ; Kolmos, Hans Jorn ; Larsson, Anders ; Arnlov, Johan ; Jakobsen, Janus Christian ; Gluud, Christian. / Serum osteoprotegerin as a long-term predictor for patients with stable coronary artery disease and its association with diabetes and statin treatment: A CLARICOR trial 10-year follow-up substudy. In: Atherosclerosis. 2020 ; Vol. 301. pp. 8-14.
Bibtex
@article{636e668a238748988495c3a73e67b36f,
title = "Serum osteoprotegerin as a long-term predictor for patients with stable coronary artery disease and its association with diabetes and statin treatment: A CLARICOR trial 10-year follow-up substudy",
keywords = "Osteoprotegerin, Statins, Diabetes, Coronary artery disease",
author = "Mette Bjerre and Jorgen Hilden and Per Winkel and Jensen, {Gorm Boje} and Erik Kj{\o}ller and Ahmad Sajadieh and Jens Kastrup and Kolmos, {Hans Jorn} and Anders Larsson and Johan Arnlov and Jakobsen, {Janus Christian} and Christian Gluud",
year = "2020",
doi = "10.1016/j.atherosclerosis.2020.03.030",
language = "English",
volume = "301",
pages = "8--14",
journal = "Journal of atherosclerosis research",
issn = "1567-5688",
publisher = "Elsevier Ireland Ltd",
}
RIS
TY - JOUR
T1 - Serum osteoprotegerin as a long-term predictor for patients with stable coronary artery disease and its association with diabetes and statin treatment: A CLARICOR trial 10-year follow-up substudy
AU - Bjerre, Mette
AU - Hilden, Jorgen
AU - Winkel, Per
AU - Jensen, Gorm Boje
AU - Kjøller, Erik
AU - Sajadieh, Ahmad
AU - Kastrup, Jens
AU - Kolmos, Hans Jorn
AU - Larsson, Anders
AU - Arnlov, Johan
AU - Jakobsen, Janus Christian
AU - Gluud, Christian
PY - 2020
Y1 - 2020
KW - Osteoprotegerin
KW - Statins
KW - Diabetes
KW - Coronary artery disease
U2 - 10.1016/j.atherosclerosis.2020.03.030
DO - 10.1016/j.atherosclerosis.2020.03.030
M3 - Journal article
C2 - 32289619
VL - 301
SP - 8
EP - 14
JO - Journal of atherosclerosis research
JF - Journal of atherosclerosis research
SN - 1567-5688
ER -
